Skip to content
Baker Capital StrategiesMARKETS. FILINGS. PERSPECTIVE.
Powered by THEMA

BAKER CAPITAL STRATEGIES

Get the free weekly BCS email.

Selected company filings and market updates, delivered by email. Your first report will follow soon.

  • Your weekly BCS reportMarket updates and links to filings you can explore.
  • THEMA at launchWe’ll send directions for setting up your filing alerts when THEMA officially opens.

One signup for the weekly email and your free THEMA Basic account at launch.

Already registered or a CSW member?Log in to THEMA →

At least 8 characters. This also creates your free THEMA account for launch.

You’re signing up for the weekly BCS email and THEMA launch/setup updates. Unsubscribe using the link in any email. Privacy policy · Terms

BCS

Notice of Proposed Sale · 144

Encompass Health Corporation

EHCNYSEEQUITYCurrent

Notice of Proposed Sale

Filed Aug 10, 2026Accepted Aug 10, 2026, 5:10 PM EDTFiling CIK 785161Accession 0001969223-26-000876
Share

Structured filing — 144

primary_doc.xml

Open full document ↗

Notice of proposed sale. The proposed amounts below do not establish that a sale occurred.

Proposed-sale notice

Issuer
Encompass Health Corporation
Issuer CIK
0000785161
SEC file number
001-10315
Phone
205-967-7116
Person for whose account securities are to be sold
Douglas Coltharp
Relationships to issuer
Officer
Street
9001 Liberty Parkway
City
Birmingham
State / country code
AL
Postal code
35242

Securities proposed for sale

Securities proposed for sale · 1 reported row
SecurityProposed unitsAggregate market valueUnits outstandingApproximate sale dateExchangeBroker / market maker
Common Stock18,8692,365,700.8898,653,38408/10/2026NYSEUBS Financial Services Inc

Broker / market maker — proposed row 1, entry 1

Name
UBS Financial Services Inc
Street
1000 Harbor Blvd
Street (continued)
3rd Floor
City
Weehawken
State / country code
NJ
Postal code
07086

Acquisition of securities to be sold

Acquisition of securities to be sold · 5 reported rows
SecurityAcquiredNature of acquisitionAcquired fromAmount acquiredGift transactionPayment dateNature of payment
Common Stock01/01/2025RSA VestingEncompass Health Corporation7,075N08/10/2026N/A
Common Stock01/01/2025RSA VestingEncompass Health Corporation8,307N08/10/2026N/A
Common Stock02/23/2025RSA VestingEncompass Health Corporation1,161N08/10/2026N/A
Common Stock02/25/2025RSA VestingEncompass Health Corporation1,353N08/10/2026N/A
Common Stock02/28/2025RSA VestingEncompass Health Corporation973N08/10/2026N/A

Sales reported in the preceding three months

Sales reported in the preceding three months · 1 reported row
SellerSecuritySale dateAmount soldGross proceeds
Douglas ColtharpCommon Stock05/15/202627,6942,958,629

Seller — prior-sale row 1, entry 1

Name
Douglas Coltharp
Street
2736 Abingdon Road
City
Mountain Brook
State / country code
AL
Postal code
35243

Prior-sale reporting

Nothing to report for the preceding three months
N

Notice signature

Notice date
08/10/2026
Signed
/s/Mijo Suric, for UBS Financial Services Inc, as attorney-in-fact for Douglas Coltharp

Company context

Encompass Health (NYSE: EHC) is the largest owner and operator of inpatient rehabilitation hospitals in the United States. With a national footprint that includes 175 hospitals in 39 states and Puerto Rico, the Company provides high-quality, compassionate rehabilitative care for patients recovering from a major injury or illness, using advanced technology and innovative treatments to maximize recovery. Encompass Health is recognized as America’s Most Awarded Leader in Inpatient Rehabilitation by Newsweek and Statista and is ranked among Fortune's World’s Most Admired Companies™, Forbes’ America’s Best Companies and Becker’s Healthcare’s Top Places to Work in Healthcare. For more information, visit encompasshealth.com, or follow us on our newsroom, X, Instagram and Facebook.

Current securities

Historical securities (1)

Recent company filings

  1. 10-Q filingNov 3, 2026
  2. Results of Operations and Financial Condition · Regulation FD DisclosureOct 28, 2026
  3. 4 filingSep 1, 2026
  4. 4 filingSep 1, 2026
  5. 144 filingAug 31, 2026

Privacy choices

BCS measures page use with Google Analytics using regional consent settings. You can change your preference here. Charts and market data remain available.

Essential functions — always available. Security, navigation, registration and remembering these choices.

Audience analytics

Analytics cookies are off by default for visitors Google identifies in the EEA, UK or Switzerland until allowed. Limited measurement without analytics cookies may still occur under those regional defaults.

TradingView charts, quotes and the economic calendar load automatically as page content. TradingView receives network and browser information and may collect its own usage analytics. This choice controls BCS’s Google Analytics only.

Google advertising is not enabled. Direct sponsor links do not load advertising trackers on BCS.

Turning analytics off stops future Google Analytics activity here. It does not erase information already received by the provider. Read the privacy policy.